Filing Flows › Elite Pharmaceuticals (ELTP) › Net income
Elite Pharmaceuticals (ELTP) net income by quarter
Elite Pharmaceuticals' net income was $5.9M in Q1 FY27 (first quarter fiscal 2027), -68% from Q4 FY26. Over the last 5 quarters it ranged from $5.9M (Q1 FY27) to $18.6M (Q3 FY26).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $5.9M | -68% | — |
| Q4 FY26 | $18.5M | -0.7% | +9% |
| Q3 FY26 | $18.6M | +36% | — |
| Q2 FY26 | $13.7M | -19% | — |
| Q4 FY25 | $17.0M | — | — |
Q1 FY27 at a glance
Elite Pharmaceuticals, Q1 FY27: revenue $32.4M (-20% year over year), operating margin 23.3%, net earnings $5.9M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Elite Pharmaceuticals' net income?
Elite Pharmaceuticals' net income was $5.9M in Q1 FY27 (first quarter fiscal 2027), -68% from Q4 FY26.
How has Elite Pharmaceuticals' net income changed?
Over the last 5 quarters it ranged from $5.9M (Q1 FY27) to $18.6M (Q3 FY26).